Literature DB >> 24900296

Sulfonate-containing thiiranes as selective gelatinase inhibitors.

Sebastian A Testero1, Mijoon Lee1, Rachel T Staran1, Mana Espahbodi1, Leticia I Llarrull1, Marta Toth1, Shahriar Mobashery1, Mayland Chang1.   

Abstract

Matrix metalloproteinases (MMPs) are important zinc-dependent endopeptidases. Two members of this family of enzymes called gelatinases (MMP-2 and MMP-9) have been implicated in a number of human diseases, including cancer, neurological and cardiovascular diseases, and inflammation, to name a few. We describe in this report the preparation and evaluation of two structural types of thiirane inhibitors that show selectivity toward gelatinases. The biphenyl series targets both gelatinases, whereas the monophenyl analogues exhibit potent inhibition of only MMP-2. The latter structural type also exhibits improved water solubility and metabolic stability, both traits desirable for progress of these molecules forward in gelatinase-dependent animal models of disease.

Entities:  

Keywords:  Slow-binding gelatinase inhibitors; matrix metalloproteinases; thiiranes

Year:  2010        PMID: 24900296      PMCID: PMC4018095          DOI: 10.1021/ml100254e

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  20 in total

Review 1.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

Review 2.  Extracellular matrix remodelling: the role of matrix metalloproteinases.

Authors:  Ivan Stamenkovic
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

Review 3.  Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility.

Authors:  György Dormán; Sándor Cseh; István Hajdú; László Barna; Dénes Kónya; Krisztina Kupai; László Kovács; Péter Ferdinandy
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

4.  Recent advances in MMP inhibitor design.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Cancer Metastasis Rev       Date:  2006-03       Impact factor: 9.264

5.  Design, synthesis, and characterization of potent, slow-binding inhibitors that are selective for gelatinases.

Authors:  M Margarida Bernardo; Stephen Brown; Zhi-Hong Li; Rafael Fridman; Shahriar Mobashery
Journal:  J Biol Chem       Date:  2002-01-14       Impact factor: 5.157

6.  Metabolism of a highly selective gelatinase inhibitor generates active metabolite.

Authors:  Mijoon Lee; Adriel Villegas-Estrada; Giuseppe Celenza; Bill Boggess; Marta Toth; Gloria Kreitinger; Christopher Forbes; Rafael Fridman; Shahriar Mobashery; Mayland Chang
Journal:  Chem Biol Drug Des       Date:  2007-10-10       Impact factor: 2.817

Review 7.  Progress in the development of matrix metalloproteinase inhibitors.

Authors:  GuoGang Tu; WenFang Xu; HuiMing Huang; ShaoHua Li
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

8.  Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue.

Authors:  Peng Tao; Jed F Fisher; Qicun Shi; Thom Vreven; Shahriar Mobashery; H Bernhard Schlegel
Journal:  Biochemistry       Date:  2009-10-20       Impact factor: 3.162

9.  A potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic disposition.

Authors:  Mijoon Lee; Giuseppe Celenza; Bill Boggess; Jennifer Blase; Qicun Shi; Marta Toth; M Margarida Bernardo; William R Wolter; Mark A Suckow; Dusan Hesek; Bruce C Noll; Rafael Fridman; Shahriar Mobashery; Mayland Chang
Journal:  Chem Biol Drug Des       Date:  2009-02       Impact factor: 2.817

10.  Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases.

Authors:  Christopher Forbes; Qicun Shi; Jed F Fisher; Mijoon Lee; Dusan Hesek; Leticia I Llarrull; Marta Toth; Michael Gossing; Rafael Fridman; Shahriar Mobashery
Journal:  Chem Biol Drug Des       Date:  2009-10-06       Impact factor: 2.817

View more
  12 in total

1.  Detection of MMP-2 and MMP-9 activity in vivo with a triple-helical peptide optical probe.

Authors:  Walter J Akers; Baogang Xu; Hyeran Lee; Gail P Sudlow; Gregg B Fields; Samuel Achilefu; W Barry Edwards
Journal:  Bioconjug Chem       Date:  2012-02-29       Impact factor: 4.774

Review 2.  Demystifying the extracellular matrix and its proteolytic remodeling in the brain: structural and functional insights.

Authors:  Venkat Raghavan Krishnaswamy; Amit Benbenishty; Pablo Blinder; Irit Sagi
Journal:  Cell Mol Life Sci       Date:  2019-06-13       Impact factor: 9.261

3.  Structure-Activity Relationship for Thiirane-Based Gelatinase Inhibitors.

Authors:  Mijoon Lee; Masahiro Ikejiri; Dennis Klimpel; Marta Toth; Mana Espahbodi; Dusan Hesek; Christopher Forbes; Malika Kumarasiri; Bruce C Noll; Mayland Chang; Shahriar Mobashery
Journal:  ACS Med Chem Lett       Date:  2012-05-02       Impact factor: 4.345

4.  Selective water-soluble gelatinase inhibitor prodrugs.

Authors:  Major Gooyit; Mijoon Lee; Valerie A Schroeder; Masahiro Ikejiri; Mark A Suckow; Shahriar Mobashery; Mayland Chang
Journal:  J Med Chem       Date:  2011-09-06       Impact factor: 7.446

5.  Extension of the CHARMM General Force Field to sulfonyl-containing compounds and its utility in biomolecular simulations.

Authors:  Wenbo Yu; Xibing He; Kenno Vanommeslaeghe; Alexander D MacKerell
Journal:  J Comput Chem       Date:  2012-07-23       Impact factor: 3.376

6.  Exploration of mild copper-mediated coupling of organotrifluoroborates in the synthesis of thiirane-based inhibitors of matrix metalloproteinases.

Authors:  Sebastian A Testero; Renee Bouley; Jed F Fisher; Mayland Chang; Shahriar Mobashery
Journal:  Bioorg Med Chem Lett       Date:  2010-12-29       Impact factor: 2.823

7.  Acceleration of diabetic wound healing using a novel protease-anti-protease combination therapy.

Authors:  Ming Gao; Trung T Nguyen; Mark A Suckow; William R Wolter; Major Gooyit; Shahriar Mobashery; Mayland Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

8.  Water-soluble mmp-9 inhibitor prodrug generates active metabolites that cross the blood-brain barrier.

Authors:  Wei Song; Zhihong Peng; Major Gooyit; Mark A Suckow; Valerie A Schroeder; William R Wolter; Mijoon Lee; Masajiro Ikejiri; Jiankun Cui; Zezong Gu; Mayland Chang
Journal:  ACS Chem Neurosci       Date:  2013-05-30       Impact factor: 4.418

9.  Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury.

Authors:  Mijoon Lee; Zhenzhou Chen; Brittany N Tomlinson; Major Gooyit; Dusan Hesek; María Raquel Juárez; Rasheeq Nizam; Bill Boggess; Elena Lastochkin; Valerie A Schroeder; William R Wolter; Mark A Suckow; Jiancun Cui; Shahriar Mobashery; Zezong Gu; Mayland Chang
Journal:  ACS Chem Neurosci       Date:  2015-08-14       Impact factor: 4.418

10.  Discovery of Mechanism-Based Inactivators for Human Pancreatic Carboxypeptidase A from a Focused Synthetic Library.

Authors:  Sebastián A Testero; Carla Granados; Daniel Fernández; Pablo Gallego; Giovanni Covaleda; David Reverter; Josep Vendrell; Francesc X Avilés; Irantzu Pallarès; Shahriar Mobashery
Journal:  ACS Med Chem Lett       Date:  2017-09-22       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.